Similar Stories to This Obesity-drug Startup Emerged From Stealth With $290 Million And Plans To Take On Wegovy And Zepbound  on Bing News

Metsera is taking a ‘Lego kit’ approach to finding a next-generation weight-loss treatment. Biopharma startup Metsera turned heads in April when it emerged from stealth, announcing $290 million in funding from prestigious backers—an all-star roster of scientists and executives—and a portfolio of drug assets all focused on what may be the most lucrative pharmaceutical opportunity ever: obesity.

Topics:  lego   biopharma   metsera   april   startup   million   emerged from stealth   
BING NEWS:
  • Versant startup sets out to make a new type of obesity drug
    The startup, Pep2Tango, is combining four methods of accelerating weight loss into one medicine in the hopes of developing a treatment that can improve upon drugs like Wegovy and Zepbound.
    11/21/2024 - 1:48 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News